Top Markets
#1 GEKKO GEKKO +53.94%
#2 Helium Helium +42.04%
#3 Pons Pons +20.06%
#4 Main Street Yield Main Street Yield +17.48%
#5 龙虾 (Lobster) 龙虾 (Lobster) +16.94%
#6 o1.exchange o1.exchange +14.33%
#7 Ontology Gas Ontology Gas +13.66%
#8 Collect on Fanable Collect on Fanable +13.51%
#9 OpenGradient OpenGradient +11.97%
#10 Velvet Velvet +11.60%
Coin of the day
GEKKO GEKKO
Settings
Language
ENGLISH
Currency
USD
Theme
Chengdu Easton Biopharmaceuticals Co., Ltd. Chengdu Easton Biopharmaceuticals Co., Ltd.

Chengdu Easton Biopharmaceuticals Co., Ltd.

688513
Rank in Stocks #9010
Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise... Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise dedicated to the full spectrum of drug development, encompassing research, development, production, and market distribution of medicinal products. The company offers finished medications tailored for various medical disciplines, including pain management (anesthetics/analgesics), cardiovascular health, oncology, and pediatrics. Beyond ready-to-use drugs, it also manufactures active pharmaceutical ingredients (APIs) for a broader range of therapeutic areas, such as cancer treatment, heart conditions, pain relief, anti-inflammatory uses, gastrointestinal issues, antiemetics, neurological and psychiatric disorders, and urinary system ailments. Established in 2009, the firm is headquartered in Chengdu, China.
Share Price
$6.32
Last synced: 2026-08-28
Market Cap
$1.11B
Change (1 day)
-1.63%
Change (1 year)
-31.28%
Country
CN
Trade Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)

Category

Healthcare
Operating Margin for Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)
Operating Margin as of 2026 TTM: 0.00%
According to Chengdu Easton Biopharmaceuticals Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Chengdu Easton Biopharmaceuticals Co., Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.